Long-term outcomes of volume de-escalation for breast nodal irradiation
Improved patients' selection and a broader use of systemic therapy could make de-escalation a feasible option. However, this approach should be avoided in patients with extensive nodal involvement, specific molecular subtypes, or comorbidities that prevent the use of chemotherapy.
Authors
- G. S. Rossano
- Luisa De Sanctis (ORCID: https://orcid.org/0000-0003-2113-6196)
- Riccardo Ray Colciago (ORCID: https://orcid.org/0000-0002-3867-2844)
- Valeria Faccenda (ORCID: https://orcid.org/0009-0001-9584-637X)
- S. Trivellato (ORCID: https://orcid.org/0000-0002-7518-1446)
- Chiara Chissotti
- Federica Ferrario
- Stefano Arcangeli (ORCID: https://orcid.org/0000-0003-3880-8876)
- Denis Panizza (ORCID: https://orcid.org/0000-0002-8309-924X)
Institutions
- Azienda Ospedaliera San Gerardo (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Milano-Bicocca (IT)
Publication Details
- Journal
- Breast Cancer Research and Treatment
- Published
- 2025-02-24
- DOI
- https://doi.org/10.1007/s10549-025-07652-3
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Università degli Studi di Milano-Bicocca